VRAX Virax Biolabs Accounting Capitalization

VRAX (viraxbiolabs.com) - company brandmark

As an authoritative player in early virus detection, Virax Biolabs Group (VRAX) develops precise immune systems, generating revenue through the sale of diagnostic kits for influenza and hepatitis monitoring. This chart reflects current share prices fixed at 0.02. Meanwhile, the brand's production capacities are operating normally, undergoing technical modernization to launch updated test series.

VRAX Virax Biolabs Book Capitalization (04/28/2023 - 10/29/2026)

Virax Biolabs - analytical breakdowns and key metrics (VRAX)

- price and consensus price forecast:
Stock Price Virax Biolabs Corp|VRAX - Consensus Target
- market capitalization data:
Market Capitalization Virax Biolabs Group Limited|VRAX - Total Company Value
- book capitalization data:
Accounting Value per Share Virax Biolabs|VRAX - Book Capitalization|Market-to-Book Ratio viraxbiolabs.com|VRAX - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Virax Biolabs Group|VRAX - Long-Term Debt to Capital|Short-Term Debt to Capital Virax Biolabs Group Limited|VRAX - Company Debts|Debt to Book Value Ratio Virax Biolabs Group Limited|VRAX - Company Long-Term Debts|Company Short-Term Debts Virax Biolabs
Basic company analysis:VRAX - Virax Biolabs Corp
Mass-produced product of Virax Biolabs

Book value capitalization represents a daily revaluation of net assets, capturing the real value of equity under inflationary pressure. The current value of 0.02 for the firm's book capital reflects the financial stability of Virax Biolabs Group (VRAX), which is critical for scaling the diagnostic laboratory network and expanding test distribution into emerging markets.

Competitor analysis for Virax Biolabs Group

Agilent Corp (A) - Book Capitalization|Company Net Assets Quest Diagnostics|ILMN (illumina.com) - Accounting Capitalization|Company Book Value EXAS|Company Net Assets Revvity Inc|Bio-Rad Laboratories Inc - Book Capitalization|Total Stockholders' Equity Anbio Corp (NNNN)|SHC - Book Capitalization|Accounting Capitalization quidel.com QDEL|OPKO Health - Book Capitalization|CDNA: Book Capitalization|Company Book Value Maravai LifeSciences Corp|Fulgent (FLGT) - Accounting Capitalization|LAB (Standard BioTools Inc.) - Book Capitalization|Book Capitalization CTKB|Company Book Value OraSure (OSUR)|Company Book Value exagen.com XGN|MDXH: Company Net Assets|Lucid Diagnostics, Inc - Total Stockholders' Equity|Company Book Value PRE (Prenetics Global Ltd)|IMDX - Book Valuation of Business|trinitybiotech.com - Book Capitalization|PRPH (ProPhase Labs Inc) - Book Valuation of Business|AIMD: Company Book Value|Book Valuation of Business CoDx (CODX)|Company Net Assets Heart Test Laboratories (HSCS)|Company Book Value biomerica.com (BMRA)|Book Capitalization CDIO|Bluejay Diagnostics Inc - Book Valuation of Business|Company Book Value Vermillion (AWH)|AXDX - Accounting Value of Company|CNTG: Book Capitalization|Book Capitalization Enzo Biochem|Company Net Assets Fresh2 Group Ltd (FRES)|Accounting Capitalization GTG Labs (GENE)|23andMe Inc. (ME) - Company Net Assets|Accounting Value of Company Psychemedics Inc (PMD)